Skip to main content
Signal8

MANUSO JAMES S J

SEC insider (Form 3/4/5 filer). CIK 0001236365. Director at Opus Genetics, Inc. (IRD) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Apr 20, 2026. Located in DURHAM, NC.

Companies MANUSO JAMES S J has filed insider reports for

  • Opus Genetics, Inc. (IRD): Director
  • TuHURA Biosciences, Inc./NV (HURA): Director
MANUSO JAMES S J profile photo

MANUSO JAMES S J

CIK: 0001236365

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Opus Genetics, Inc. logo
IRD

Opus Genetics, Inc.

Director
TuHURA Biosciences, Inc./NV logo
HURA

TuHURA Biosciences, Inc./NV

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 20, 2026
    Award
    Direct
    24.4K shares-
  • TuHURA Biosciences, Inc./NV logo
    HURA

    TuHURA Biosciences, Inc./NV

    Feb 12, 2026
    Award

    Options (Right to Buy)

    Direct
    156.2K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Jan 1, 2026
    Award
    Direct
    31.2K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 30, 2025
    Award
    Direct
    79.5K shares-
  • TuHURA Biosciences, Inc./NV logo
    HURA

    TuHURA Biosciences, Inc./NV

    Jan 2, 2025
    Award

    Options (Right to Buy)

    Direct
    59.6K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Jan 2, 2025
    Award
    Direct
    50.2K shares-
  • Kintara Therapeutics, Inc. logo
    KTRA

    Kintara Therapeutics, Inc.

    Oct 18, 2024
    Award

    Options (Right to Buy)

    Direct
    13.6K shares-
  • Kintara Therapeutics, Inc. logo
    KTRA

    Kintara Therapeutics, Inc.

    Oct 18, 2024
    Award

    Options (Right to Buy)

    Direct
    13.6K shares-

1-8 of 8